"The genital wart vaccine Gardasil is highly effective at preventing pre-cancerous anal lesions in younger gay men, according to the results of a study presented to a recent conference.
"Delegates to the European Research Organization on Genital Infection and Neoplasia were told that Gardasil reduced the risk of pre-cancerous anal lesions by 78% in a Phase III, randomised, placebo-controlled trial involving gay and other men who have sex with men aged between 18 and 26.
"Gay men, especially those with HIV, have higher rates of anal cancer than those seen in the general population, therefore the high efficacy of the vaccine is encouraging."
Read more in Aidsmap, February 24, 2010.
0 comments:
Post a Comment